Paragon 28 (FNA) Competitor Comparison
We are evaluating the key criteria listed to compare Paragon 28 (FNA) against its competitors in the Medical Devices industry.
Market Capitalization
34 / 92Gross Profits
37 / 85Total Revenue
39 / 89EBITDA
51 / 90Free Cashflow
81 / 90Quick Ratio
70 / 90Earnings per Share
41 / 90Dividend yield
0 / 8Total Cash
66 / 90Performance 3 years
55 / 92Performance 5 years
55 / 92Performance 10 years
54 / 92Linearity 3 years
41 / 92Linearity 5 years
37 / 92Linearity 10 years
29 / 92Total Rank
40 / 92Dividend Rank
44 / 92Valuation Rank
64 / 92Piotroski Rank
72 / 92Muliplier Rank
42 / 92Free Cashflow - FNA ranking 81 / 90
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.